1. Home
  2. CRVS vs LXFR Comparison

CRVS vs LXFR Comparison

Compare CRVS & LXFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRVS
  • LXFR
  • Stock Information
  • Founded
  • CRVS 2014
  • LXFR 1898
  • Country
  • CRVS United States
  • LXFR United States
  • Employees
  • CRVS N/A
  • LXFR N/A
  • Industry
  • CRVS Biotechnology: Pharmaceutical Preparations
  • LXFR Major Chemicals
  • Sector
  • CRVS Health Care
  • LXFR Industrials
  • Exchange
  • CRVS Nasdaq
  • LXFR Nasdaq
  • Market Cap
  • CRVS 305.4M
  • LXFR 335.4M
  • IPO Year
  • CRVS 2016
  • LXFR 2012
  • Fundamental
  • Price
  • CRVS $5.75
  • LXFR $13.42
  • Analyst Decision
  • CRVS Strong Buy
  • LXFR
  • Analyst Count
  • CRVS 4
  • LXFR 0
  • Target Price
  • CRVS $15.00
  • LXFR N/A
  • AVG Volume (30 Days)
  • CRVS 518.7K
  • LXFR 135.6K
  • Earning Date
  • CRVS 08-07-2025
  • LXFR 10-28-2025
  • Dividend Yield
  • CRVS N/A
  • LXFR 3.87%
  • EPS Growth
  • CRVS N/A
  • LXFR N/A
  • EPS
  • CRVS N/A
  • LXFR 0.90
  • Revenue
  • CRVS N/A
  • LXFR $403,800,000.00
  • Revenue This Year
  • CRVS N/A
  • LXFR $3.12
  • Revenue Next Year
  • CRVS N/A
  • LXFR $3.31
  • P/E Ratio
  • CRVS N/A
  • LXFR $13.74
  • Revenue Growth
  • CRVS N/A
  • LXFR 5.60
  • 52 Week Low
  • CRVS $2.54
  • LXFR $9.41
  • 52 Week High
  • CRVS $10.00
  • LXFR $15.64
  • Technical
  • Relative Strength Index (RSI)
  • CRVS 65.10
  • LXFR 64.00
  • Support Level
  • CRVS $5.28
  • LXFR $12.32
  • Resistance Level
  • CRVS $5.64
  • LXFR $13.86
  • Average True Range (ATR)
  • CRVS 0.30
  • LXFR 0.45
  • MACD
  • CRVS 0.03
  • LXFR 0.11
  • Stochastic Oscillator
  • CRVS 77.70
  • LXFR 78.85

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

About LXFR Luxfer Holdings PLC

Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.

Share on Social Networks: